These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 9321741

  • 1. Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats.
    Black MJ, Kanellakis P, Bobik A.
    J Hypertens; 1997 Sep; 15(9):945-54. PubMed ID: 9321741
    [Abstract] [Full Text] [Related]

  • 2. Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity.
    Oddie CJ, Dilley RJ, Kanellakis P, Bobik A.
    J Hypertens; 1993 Jul; 11(7):717-24. PubMed ID: 8228190
    [Abstract] [Full Text] [Related]

  • 3. Relationship between cardiovascular hypertrophy and cardiac baroreflex function in spontaneously hypertensive and stroke-prone rats.
    Minami N, Head GA.
    J Hypertens; 1993 May; 11(5):523-33. PubMed ID: 8390524
    [Abstract] [Full Text] [Related]

  • 4. Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension.
    Dominiczak AF, Devlin AM, Lee WK, Anderson NH, Bohr DF, Reid JL.
    Hypertension; 1996 Mar; 27(3 Pt 2):752-9. PubMed ID: 8613236
    [Abstract] [Full Text] [Related]

  • 5. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
    O'Sullivan JB, Black MJ, Bertram JF, Bobik A.
    J Hypertens; 1994 Oct; 12(10):1163-70. PubMed ID: 7836732
    [Abstract] [Full Text] [Related]

  • 6. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR, Widdop RE.
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cardiac growth during high and low dose perindopril treatment in spontaneously hypertensive rats.
    Black MJ, Bertram JF, Johnston CI.
    Clin Exp Pharmacol Physiol; 1996 Aug; 23(6-7):605-7. PubMed ID: 8800599
    [Abstract] [Full Text] [Related]

  • 11. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure.
    Christensen KL, Jespersen LT, Mulvany MJ.
    J Hypertens; 1989 Feb; 7(2):83-90. PubMed ID: 2522478
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II induces cardiovascular hypertrophy in perindopril-treated rats.
    Black MJ, Bertram JF, Campbell JH, Campbell GR.
    J Hypertens; 1995 Jun; 13(6):683-92. PubMed ID: 7594427
    [Abstract] [Full Text] [Related]

  • 13. Persistent effects on blood pressure and renal haemodynamics following chronic angiotensin converting enzyme inhibition with perindopril.
    Harrap SB, Nicolaci JA, Doyle AE.
    Clin Exp Pharmacol Physiol; 1986 Jun; 13(11-12):753-65. PubMed ID: 3030586
    [Abstract] [Full Text] [Related]

  • 14. AT1 receptor antagonist treatment caused persistent arterial functional changes in young spontaneously hypertensive rats.
    Gillies LK, Lu M, Wang H, Lee RM.
    Hypertension; 1997 Dec; 30(6):1471-8. PubMed ID: 9403569
    [Abstract] [Full Text] [Related]

  • 15. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats.
    Makino N, Sugano M, Otsuka S, Hata T.
    Hypertension; 1997 Oct; 30(4):796-802. PubMed ID: 9336375
    [Abstract] [Full Text] [Related]

  • 16. Dose-dependent effects of perindopril on blood pressure and small-artery structure.
    Thybo NK, Korsgaard N, Eriksen S, Christensen KL, Mulvany MJ.
    Hypertension; 1994 May; 23(5):659-66. PubMed ID: 8175177
    [Abstract] [Full Text] [Related]

  • 17. Cross-over study comparing effects of treatment with an angiotensin converting enzyme inhibitor and an angiotensin II type 1 receptor antagonist on cardiovascular changes in hypertension.
    Gillies LK, Werstiuk ES, Lee RM.
    J Hypertens; 1998 Apr; 16(4):477-86. PubMed ID: 9797193
    [Abstract] [Full Text] [Related]

  • 18. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR.
    Li JS, Sharifi AM, Schiffrin EL.
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):75-83. PubMed ID: 9268224
    [Abstract] [Full Text] [Related]

  • 19. Effect of perindopril on cardiovascular hypertrophy of the SHR: respective roles of reduced blood pressure and reduced angiotensin II levels.
    Black MJ, Campbell JH, Campbell GR.
    Am J Cardiol; 1993 Jun 24; 71(17):17E-21E. PubMed ID: 8328362
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.